NCT05051696View on ClinicalTrials.gov

Intra-tumor Injection of Oncolytic Viruses H101 Combined With or Without Radiotherapy in Refractory/Recurrent Gynecological Malignancies

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

September 26, 2021

Primary Completion Date

March 30, 2024

Study Completion Date

March 30, 2025

Conditions
Genital Neoplasms, Female
Interventions
DRUG

H101

Intra-tumor injected oncolytic viruses H101 within 5 consecutive days,3 weeks for a cycle (1-4cycles)

Trial Locations (1)

710061

The First Affiliated Hospital of Xi'an Jiao Tong University, Xi'an

All Listed Sponsors
lead

Liu Zi

OTHER